某二级甲等综合医院住院患者抗菌药物治疗前-病原学送检情况分析

doi:10.3969/j.issn.1006-5253.2023.06.00４

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (2503 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective To understand the pathogen submission of inpatients before antimicrobial treatment in a upper second-class general hospital from 2020 to 2022, so as to provide a basis for hospital infection management.Methods The data of pathogen submission and positive detection of hospitalized patients before antimicrobial treatment, before combined use of key antibiotics and hospital infection diagnosis from 2020 to 2022 were retrospectively collected, and the submission rate and positive detection rate were analyzed.Results During the 3 years, the rate of pathogen detection before the antibiotic treatment increased, and the difference was statistically significant (Z=17.556, P＜0.01). The positive detection rate before the treatment decreased, and the difference was statistically significant (Z＝-8.398, P＜0.01). The rates of pathogenic detection were 48.78%, 94.68% and 69.85% before the antibiotic treatment, before the combination with key antibiotics, and nosocomial infection diagnosis, and the positive detection rates were 24.25%, 46.31% and 38.89%.Conclusion The rate of pathogen detection before the antibiotic treatment in the hospital cannot meet the national target requirements, and the positive detection rate of each department is low. The hospital should strengthen the collection and submission of microbial specimens.

Key words： upper second-class general hospital pathogen examination antimicrobial treatment

Received: 25 July 2023

PACS:

Fund:

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Han Shuanghai
	Ma Dehui
	Tian Weicai
	Chen Tao

Cite this article:

Han Shuanghai,Ma Dehui,Tian Weicai, et al. Analysis of etiological examination of inpatients before antibiotic therapy in a upper secondclass general hospital[J]. journal1, 2023, 30(6): 418-421.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2023.06.00４ OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2023/V30/I6/418

［1］国家卫生健康委办公厅．国家卫生健康委办公厅关于印发2021年国家医疗质量安全改进目标的通知［EB/OL］．（2021-02-09）［202３-07-25］.https://www.gov.cn/zhengce/zhengceku/2021-02/22/content_5588240.htm．

［2］陈晓旭，李松琴，刘娟，等．三级医院住院患者抗菌药物治疗前病原学送检率管理现状调［J］．中国感染控制杂志，2023，22(5)：532-538．DOI: 10.12138/j.issn.1671-9638.20233700.

［3］孙丽媛，金丁萍，严继承，等．166所综合医院医院感染管理监控指标调［J］．中华医院感染学杂志，2017，27(17)：4034-4037．

［4］杨俊林，查筑红，杨昆，等．贵州省234所医院多药耐药菌检出及抗菌药物使用现况调［J］．中华医院感染学杂志，2020，30(1)：49-53．DOI: 10.11816/cn.ni.2020-196041.

［5］马旭东，陈心航，姚宏武，等．抗菌药物治疗前病原学送检率指标的管理应用现状［J］．中华医院感染学杂志，2022，32(6)：936-940．DOI: 10.11816/cn.ni.2022-213763.

［6］林丹，查筑红，李凌竹，等．贵州省医院感染管理质量控制指标的调查分析［J］．中国消毒学杂志，2022，39(11)：834-836．DOI: 10.11726/j.issn.1001-7658.2022.11.011.

［7］SIM-ES A S, MAIA M R, GREG-RIO J, et al. Participatory implementation of an antibiotic stewardship programme supported by an innovative surveillance and clinical decision-support system［J］. J Hosp Infect, 2018, 100(3):257-264. DOI: 10.1016/j.jhin.2018.07.034.

［8］周宁，张晓霞，路璐．住院患者抗菌药物治疗前病原学送检水平干预效果评价［J］．中国感染控制杂志，2023，22(3)：334-338．DOI: 10.12138/j.issn.1671-9638.20232303.

［9］曹迪，何炜婧，钟海军，等．抗菌药物科学化管理提高外科住院患者病原学送检率［J］．中国新药与临床杂志，2021，40(9)：662-665．DOI: 10.14109/j.cnki.xyylc.2021.09.12.

［10］钟平．不同临床标本微生物检验的阳性率结果研究［J］．中国卫生标准管理，2017，8(9)：108-110．DOI: 10.3969/j.issn.1674-9316.2017.09.062.［11］LAO Y Q, TANG Q J, ZENG J, et al. Effect analysis of multi-department cooperation in improving etiological submission rates before antibiotic treatment［J］. Int J Qual Health Care, 2023, 35(2):mzad018. DOI: 10.1093/intqhc/mzad018.

［12］中华预防医学会医院感染控制分会．临床微生物标本采集和送检指南［J］．中华医院感染学杂志，2018，28(20)：3192-3200．

［13］周水红，王青，杨金莲，等．基于医院绩效考核的医院感染管理质量考核指标体系的构建与评价［J］．中国感染控制杂志，2020，19(9)：773-779．DOI: 10.12138/j.issn.1671-9638.20206221.

［14］张小亮，李芳斌，袁小龙，等．抗菌药物联合用药增加医院感染发生风险的研究［J］．中国消毒学杂志，2022，39(7)：513-517．DOI: 10.11726/j.issn.1001-7658.2022.07.011.